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Abstract Sodium^hydrogen exchanger regulatory factor iso-
form-1 (NHERF-1) and NHERF-2 are two structurally related
PDZ-domain-containing protein adapters that e¡ectively trans-
duce cyclic AMP (cAMP) signals that inhibit NHE3, the so-
dium^hydrogen exchanger isoform present at the apical surface
of kidney and gut epithelia. The mouse renal proximal tubule
expresses both NHERF isoforms, suggesting their redundant
functions as regulators of renal electrolyte metabolism. To de-
¢ne the role of NHERF-1 in the physiological control of NHE3,
we analyzed NHE3 activity in isolated brush border membrane
(BBM) preparations from renal proximal tubules of wild-type
(WT) and NHERF-1 (3/3) mice. Basal Na+^H+ exchange was
indistinguishable in BBMs from WT and NHERF-1 (3/3) mice
(0.967 0.08 and 0.95 7 0.10 nmol/mg protein/10 s, respectively).
Activation of membrane bound cAMP-dependent protein kinase
(PKA) by cAMP inhibited NHE3 activity in WT BBMs
(0.557 0.07 nmol/mg protein/10 s or 407 9%, P6 0.01) but
had no discernible e¡ect on Na+^H+ exchange in the
NHERF-1 (3/3) BBM (0.977 0.07 nmol/mg protein/10 s;
P=not signi¢cant). This was associated with a signi¢cant de-
crease in cAMP-stimulated phosphorylation of NHE3 immuno-
precipitated from solubilized NHERF-1 (3/3) BBMs. As the
protein levels for NHE3, NHERF-2, PKA and ezrin were not
changed in the NHERF-1 (3/3) BBMs, the data suggest a
unique role for NHERF-1 in cAMP-mediated inhibition of
NHE3 activity in the renal proximal tubule of the mouse.
A 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Analysis of the transport activity of Naþ^Hþ Exchanger
isoform-3 (NHE3) reconstituted in arti¢cial liposomes and
expressed in PS120 cells established a critical role for the
Naþ^Hþ Exchanger Regulatory Factor (NHERF) proteins
in mediating cAMP signals that inhibit Naþ^Hþ exchange
[1^3]. NHERF-1 and NHERF-2 were de¢ned as two structur-
ally related PDZ (PSD-95/Discs large/ZO-1) domain-contain-
ing proteins that functioned as adapters to link NHE3 in the
plasma membrane to the actin-binding protein, ezrin, and
thereby to the underlying actin cytoskeleton. Ezrin functioned
as a cAMP-dependent protein kinase (PKA) anchoring pro-
tein or AKAP and thus recruited PKA to the NHE3/NHERF/
ezrin complex [4^7]. This signi¢cantly enhanced the PKA-
mediated phosphorylation of NHE3 and inhibition of its
transport activity in response to hormones that increased in-
tracellular cAMP [4,8]. In such studies, the two NHERF pro-
teins functioned in an essentially identical manner. Thus, the
physiological relevance of NHERF-1 and NHERF-2 in tissues
that expressed both proteins remains unknown.
The mouse proximal convoluted tubule, by contrast to the
rat, expresses both NHERF-1 and NHERF-2, further sug-
gesting redundant functions for the two protein adapters in
the control of renal electrolyte metabolism [9,10]. The gener-
ation of the NHERF-1 null mouse, however, established a
unique role for NHERF-1 in dictating the apical localization
of a NHERF target, the sodium-phosphate cotransporter,
Npt2. These studies indicated that NHERF-2 still present in
renal proximal tubules of the NHERF-1 (3/3) mice could
not rescue the loss of NHERF-1 function in the mutant
mouse kidney [10]. In this present study, we investigate the
potential role of the two NHERF isoforms in cAMP-medi-
ated inhibition of NHE3 assayed in puri¢ed BBMs from WT
and NHERF-1 (3/3) mice. The results strongly argue that
while NHERF-1 was not required for the expression or apical
targeting of NHE3 in the proximal tubule, it plays a crucial
role in facilitating cAMP-mediated phosphorylation of NHE3
and inhibition of its transport activity, a function that was not
complimented by the presence of NHERF-2 in these mem-
branes. Thus, the data provided further evidence that the
two NHERF isoforms serve distinct roles in the control of
renal function.
2. Methods
2.1. Preparation of mouse renal brush border membranes (BBM)
BBM vesicles were prepared from the kidney cortex excised from
groups of ¢ve to six WT CB57/BL and NHERF-1 (3/3) male mice
using modi¢cations of the magnesium aggregation method previously
described [10,11]. The enrichment of the BBM membranes was deter-
mined by Western immunoblotting for selected BBM proteins in iso-
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lated BBM and in whole kidney homogenates. The mice were main-
tained in the animals care facility, fed a rodent chow diet, and exposed
to alternating light^dark cycles according to NIH guidelines.
2.2. Cyclic AMP (cAMP) regulation of Na+^H+ exchange in isolated
mouse BBMs
To initiate phosphorylation, the BBMs were incubated in hypotonic
media containing 10 mM MgCl2, 10 mM KF, and 5 mM MES/Tris
bu¡er (pH 6.8) and 0.1 mM ATP in the absence or presence of 0.1
mM 8-bromo-cAMP for 5 min. For subsequent analysis of Naþ^Hþ
exchange, BBMs were resealed and the intravesicular space acidi¢ed
by exposure to a solution containing 227.8 mM mannitol, 42 mM
MES, 8.6 mM Tris, 13.7 mM HEPES, 0.4 mM MgSO4, 1.8 mM
MgCl2, 0.18 mM CaCl2, 1.8 mM KF and 1.8 mM ATP (pH 5.5)
for 45 min at room temperature. The vesicles were then sedimented
at 24 000Ug for 30 min and resuspended in the same solution to a
¢nal volume of 10 Wl. The vesicle suspension was then mixed with
40:1 of a solution containing 1.25 mM 22Naþ, 157.5 mM mannitol, 10
mM MES, 50 mM Tris and 80 mM HEPES (pH 7.4), with and with-
out 50 WM EIPA (ethyl isopropyl amiloride). Sodium uptake was
assayed at 22‡C in triplicate using a rapid Millipore ¢ltration tech-
nique [11].
2.3. Analysis of renal BBM phosphoproteins
For analysis of BBM phosphoproteins, radioactive Q-[32P]ATP was
included in the aforementioned phosphorylating solution. The phos-
phorylation reaction was stopped by addition of 100 nM microcystin-
LR and SDS-sample bu¡er. For quantitative analysis, 10 Wl of the
radiolabelled BBM proteins were applied to nitrocellulose using a dot-
blot apparatus and the radiolabel visualized by autoradiography and/
or scintillation counting. To qualitatively analyze the proteins phos-
phorylated, an aliquot of the samples was subjected to 10% (w/v)
SDS^PAGE, the gels dried and subjected to autoradiography. To
compare the content of speci¢c BBM proteins, non-phosphorylated
BBM proteins were subjected to 10% (w/v) SDS^PAGE, the gels
electrophoretically transferred to nitrocellulose and immunoblotted
using well characterized antibodies against NHE3, Npt2, ezrin,
NaPi Cap1, NHERF-1, NHERF-2, and RII (the type-II regulatory
subunit of PKA). For the speci¢c evaluation of NHE3 phosphory-
lation, BBMs were solubilized using 0.1% Triton-X100 and NHE3
immunoprecipitated using an anti-NHE3 antibody (Chemicon, Teme-
cula, CA, USA). The anti-NHE3 immunoprecipitates were solubilized
in SDS sample bu¡er and subjected to 10% (w/v) SDS^PAGE. The
gels were electrophoretically transferred to nitrocellulose and radio-
labelling analyzed using autoradiography. To quantify the NHE3
protein, the nitrocellulose ¢lters were subjected to Western immuno-
blotting using the anti-NHE3 antibody. All immunoblots were visu-
alized using enhanced chemical luminescence (Amersham Corpora-
tion, Arlington Heights, IL).
3. Results and discussion
NHERF-1 and NHERF-2 are apically localized modular
protein adapters that share homology in three well-de¢ned
protein interaction domains including two tandem PDZ do-
mains and a C-terminal ezrin^radixin^moesin^merlin binding
domain [2,3]. Expression of NHERF-1 or NHERF-2 in stable
PS120 ¢broblasts co-expressing the single NHE isoform,
NHE3, showed that despite di¡erences in their primary struc-
tures, both NHERF proteins bound NHE3 and participated
in the assembly of a multimeric protein complex that facili-
tated cAMP-mediated phosphorylation of NHE3 and inhibi-
tion of transport activity [3^7,12^14]. On the other hand,
although some recent experiments have indicated di¡erences
in the function of the NHERF isoforms, the precise role of
the two proteins in regulating NHE function in the intact
kidney has not been established [15]. The development of
the NHERF-1 (3/3) mouse [10], however, has provided an
opportunity to address this issue. The present biochemical
experiments were designed to investigate cAMP regulation
of NHE3 activity in isolated BBM vesicles from WT and
NHERF-1 (3/3) mice and thereby delineate the role of
NHERF-1 in the hormonal control of Naþ^Hþ exchange in
the mouse kidney.
As assessed by the presence of several BBM-associated pro-
teins, the BBMs puri¢ed from WT and NHERF-1 (3/3)
mouse kidney were enriched nine- to 11-fold over the crude
homogenates Moreover, Fig. 1 illustrates that the renal BBMs
from WT and NHERF-1 null mice contain nearly equivalent
amounts of NHE3, NHERF-2, ezrin, and another renal api-
cal PDZ-containing protein, NaPi-Cap1. As anticipated,
NHERF-1 was detected in isolated BBMs from WT but not
NHERF-1 (3/3) mice. The abundance of the sodium-depen-
dent phosphate co-transporter IIa (Npt2), a known NHERF-
1 target, was decreased in BBMs from the NHERF-1 (3/3)
animals as previously reported [10]. The BBM preparations
were predominantly right-side-out and impermeable to com-
ponents of phosphorylation mixture, speci¢cally ATP and
magnesium [11]. Thus, hypotonic shock was required to
present these reagents to the internal surface and promote
protein phosphorylation by membrane bound PKA [11]. After
the vesicles were resealed in an iced solution at pH=5.5 that
served not only to acidify the intravesicular space but also to
block protein phosphatase activity, the EIPA-sensitive com-
ponent of pH gradient-stimulated uptake of 22Naþ was mea-
sured as an index of Naþ^Hþ exchange activity [11]. As seen
in Table 1, BBMs from both WT and NHERF-1 (3/3) mice
showed similar basal Naþ^Hþ exchange consistent with the
equal presence of the NHE3 protein (Fig. 1). In contrast, the
addition of 8-bromo-cAMP resulted in a 40Q 9% decrease in
NHE3. By comparison, 8-bromo-cAMP had no discernible
e¡ect on Naþ^Hþ exchange activity measured in BBMs
+/+ -/-
NHE3
Npt2
Ezrin
NHERF-1
NHERF-2
NaPi-Cap1
Fig. 1. Comparison of proteins in renal BBMs isolated from WT
and NHERF-1 (3/3) mice. Puri¢ed BBMs (5 Wg of total protein)
were immunoblotted using monospeci¢c antibodies against NHE3,
Npt2, ezrin, NHERF-1, NHERF-2, and NaPi-Cap1.
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from NHERF-1 (3/3) mice. The total uptake of 22Naþ at 90
min, an estimate of the equilibrium value re£ecting the aver-
age vesicular volume, was not di¡erent in the two groups of
animals. These data suggest that the presence of NHERF-1 is
essential for e¡ective cAMP-mediated inhibition of Naþ^Hþ
exchange in the mouse BBM.
Previous studies showed that rabbit BBMs were principally
associated with the type-II isoform of PKA [16]. To insure
that the BBMs from WT and mutant mouse contained equiv-
alent amounts of PKA, we undertook immunoblotting anal-
yses using anti-RII antibody that recognized the type-II reg-
ulatory subunits of PKA. The data shown in Fig. 2A
established that WT and NHERF-1 (3/3) BBMs contained
near equal amounts of RII, the principal PKA regulatory
subunit associated with mouse BBMs. To evaluate the activity
of BBM-associated PKA, we also analyzed the cAMP-stimu-
lated phosphorylation of endogenous BBM proteins (Fig. 2B).
Using dot-blot analysis to quantify the relative PKA activity,
we observed nearly an identical increases in BBM protein
phosphorylation in response to 8-bromo-cAMP of 3.3 Q
0.02- and 3.0 Q 0.03-fold in WT and NHERF-1 (3/3) pro-
teins, respectively. Analysis of the overall phosphoprotein pat-
tern further con¢rmed the presence of equivalent PKA activ-
ity in both BBM preparations. (data not shown),
Previous studies showed PKA directly phosphorylated
NHE3 at speci¢c C-terminal serines to inhibit transport activ-
ity [4,17,18]. To determine the importance of NHERF-1 in
PKA-mediated regulation of NHE3 in the mouse kidney,
NHE3 protein was immunoprecipitated from detergent-solu-
bilized WT and NHERF-1 (3/3) BBMs that had previously
been phosphorylated in the presence of Q-[32P]ATP and 8-bro-
mo-cAMP. Fig. 3 shows that the addition of 8-bromo-cAMP
resulted in a signi¢cant increase in the phosphorylation of
NHE3 immunoprecipitated from WT BBMs of 1.98 Q 0.03-
fold. In contrast, 8-bromo-cAMP failed to increase NHE3
phosphorylation in BBMs from NHERF-1 (3/3) mice. Im-
munoblotting with the anti-NHE3 antibody showed that sim-
ilar amounts of NHE3 were immunoprecipitated from both
BBM preparations.
Together, the studies showed that despite the presence of
similar amounts of NHE3, type-II PKA, the AKAP, ezrin and
NHERF-2 and other related PDZ proteins, such as NaPi-
Cap1, the complete absence of NHERF-1 resulted in the in-
ability of cAMP to inhibit Naþ^Hþ exchange in the BBMs
isolated from the NHERF-1 null mouse kidney. Accordingly,
this data provides the ¢rst evidence that NHERF-1 plays a
unique role in the hormonal regulation of renal NHE3 activ-
ity. The precise reasons for the inability of NHERF-2 present
in these membranes to transduce the cAMP signals that in-
hibit NHE3 is still unclear but preliminary studies using con-
focal microscopy combined with immunohistochemistry sug-
gest a spatial separation of NHERF-1 and NHERF-2 at the
apical surface of the mouse renal proximal tubules. NHE3
appears to co-localize predominantly with NHERF-1 in this
tissue and less so with NHERF-2, ¢ndings that were present
both in WT as well as the NHERF-1 (3/3) mice. This sug-
gests that NHERF-2 may function to regulate other renal
targets. In fact, recent studies have indicated that NHERF-2
may subserve a unique role in regulating not only NHE3 but
also other transporters such as ROMK by protein kinases
other than PKA [19,20].
In summary, emerging studies using expression of NHERF
proteins in cultured cells have identi¢ed up to 30 targets of the
two NHERF isoforms [13,14]. These include various trans-
porters and ion channels, receptors, cytoskeletal and signaling
proteins, and transcription factors. Many of the targets asso-
ciate with both NHERF proteins. While some studies have
noted di¡erences in NHERF-1 and NHERF-2 in these cell-
based assays, the use of gene disruption in mouse provides
Table 1
E¡ects of cAMP on Naþ^Hþ exchange in BBMs from WT and
NHERF-1 (3/3) mice
Sodium uptake (nmol/mg protein)
NHERF-1 (+/+) NHERF-1 (3/3)
Control (10 s)
Total uptake 1.36Q0.11 1.42Q0.12
EIPA-inhibited 0.40Q0.04 0.47Q0.06
NHE3 activity 0.96Q0.08 0.95Q0.10
Plus cAMP (10 s)
Total uptake 0.98Q0.06 1.42Q0.122
EIPA-inhibited 0.43Q0.03 0.45Q0.07
NHE3 Activity 0.55Q0.07 0.97Q0.072
Control (90 min)
Total uptake 1.17Q0.06 1.11Q0.08
EIPA-inhibited 1.16Q0.11 1.19Q0.05
Plus cAMP (90 min)
Total 1.17Q0.05 1.10Q0.10
EIPA-inhibited 1.03Q0.05 1.18Q0.19
Naþ^Hþ exchange activity was de¢ned as the EIPA-sensitive com-
ponent of pH gradient-stimulated 22Naþ uptake in BBMs from
NHERF-1 (+/+) (n=7) and NHERF-1 (3/3) (n=6) mice analyzed
at initial uptake (10 s) and at equilibrium (90 min). Prior to sodium
uptake, BBMs were subjected to hypotonic shock in a solution con-
taining ATP-Mg in the absence (Control) or presence (Plus cAMP)
of 0.1 mM 8-bromo-cAMP for 5 min. Sodium transport is ex-
pressed as nmol/mg protein (meanQS.E.M.) and 2 =P6 0.01 com-
pared to WT.
Fig. 2. Comparison of PKA activity in renal BBMs from WT and
NHERF-1 (3/3) mice. A: Puri¢ed BBMs (5 Wg of total protein)
from WT and NHERF-1 (3/3) mice were immunoblotted with an
antibody against the type II regulatory subunit of PKA. B: Puri¢ed
BBMs from WT and NHERF-1 (3/3) mice were subjected to phos-
phorylation in-vitro in the presence of Q-[32P]ATP in the absence
(3) or presence (+) of 0.1 mM 8-bromo-cAMP. The phosphorylated
proteins were applied to nitrocellulose using a dot-blot apparatus
and visualized by autoradiography.
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new insights into the unique as well as the potentially over-
lapping roles of NHERF proteins in the control of mamma-
lian physiology. The NHERF-1 null mouse thus far has
shown defects in Npt2 tra⁄cking and as shown in this study,
aberrant cAMP regulation of NHE3 [10]. Future studies com-
paring the biochemistry, cell biology and physiology of ani-
mals lacking NHERF-1 and NHERF-2 should provide a bet-
ter understanding of the role of these PDZ adapter proteins in
the function and regulation of mammalian tissues.
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Fig. 3. PKA-induced phosphorylation of NHE3 in BBMs from WT
and NHERF-1 (3/3) mice. Isolated BBMs were incubated in a
phosphorylation solution containing MgCl2 and Q-[32P]ATP in the
absence (3) or presence (+) of 0.1 mM 8-bromo-cAMP (1034 M)
for 5 min. The NHE3 protein was immunoprecipitated as described
in Section 2 and the immunoprecipitates subjected to SDS^PAGE.
The top panels show representative autoradiographs of phosphory-
lated NHE3, while the lower panels show Western immunoblots for
NHE3 protein.
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